NOXOPHARM LIMITED

NOX
End-of-day quote. End-of-day quote  - 10/19
0.53AUD -6.19%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Noxopharm Limited is an Australia-based clinical-stage drug development company. The Company is focused on the treatment of cancer and cytokine release syndrome or septic shock. The Company is engaged in the drug development program, which focuses on the treatment of pancreatic cancer and glioblastoma. The Company's lead drug candidate is called Veyonda (NOX66), which is a therapy developed for chemotherapy and radiotherapy in the treatment of late-stage cancers. Its drug candidate is in Phase II clinical trials. The Company's four pillar oncology program include externally delivered radiation (DARRT) Internally delivered radiation (LuPIN), Checkpoint inhibitors (IONIC) and Chemotherapy (CEP).
Managers
Name Title
Graham Edmund Kelly Chief Executive Officer, Director & MD
Shawn van Boheemen Chief Financial Officer
Frederick Bart Non-Executive Chairman
Ian Minns Director-Clinical Development & Medical Affairs
John Wilkinson Chief Scientific Officer
Gisela Mautner Chief Medical Officer
Olivier Laczka Director-Drug Discovery & Research
Jeanette Bell Chief Operating Officer
Peter Ashley Marks Non-Executive Deputy Chairman
Boris Patkin Non-Executive Director
Shareholders
Name Equities %
Milligene Pty Ltd. 36,162,294 12.4%
Graham Edmund Kelly 36,152,294 12.4%
Eleanore Goodridge 15,185,849 5.20%
Link Traders Aust Pty Ltd. 10,472,189 3.58%
Kale Capital Corp. Ltd. 7,205,290 2.47%
Rgt Capital Fund No 5 Pty Ltd. 6,500,333 2.22%
Frederick Bart 5,618,651 1.92%
Mark Richard Scott 3,995,850 1.37%
Rhlc Pty Ltd. 3,550,000 1.21%
Suburban Holdings Pty Ltd. 3,051,677 1.04%
Sector Biopharmaceuticals
1st jan.Capi. (M$)
NOXOPHARM LIMITED8.16%116
CSL LIMITED4.59%99 388
WUXI BIOLOGICS (CAYMAN) INC.14.69%62 669
SAMSUNG BIOLOGICS CO.,LTD.5.08%47 893
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.16%40 199
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-2.56%35 585
UCB17.47%21 664
INNOVENT BIOLOGICS, INC.-4.94%14 590
WALVAX BIOTECHNOLOGY CO., LTD.55.78%14 038
GRIFOLS, S.A.-16.69%13 628
BIOMARIN PHARMACEUTICAL INC.-15.45%13 553
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED17.60%12 841
CELLTRION HEALTHCARE CO., LTD.-46.01%11 418
SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.-37.96%11 222
ZAI LAB LIMITED-25.21%9 463
CANSINO BIOLOGICS INC.31.44%9 455
SWEDISH ORPHAN BIOVITRUM AB (PUBL)41.06%7 979
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.-25.00%6 973
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.-22.01%6 866
GAN & LEE PHARMACEUTICALS.-42.44%6 579
Brand Portfolio
» More brands of Noxopharm Limited